| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $418.2K | - | |
| CFO | 26.0K | $181.2K | - | |
| Dir | 7.0K | $48.8K | - | |
| Dir | 7.0K | $48.8K | - | |
| Dir | 7.0K | $48.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2017 | Cotroneo Pat | VP, Finance And CFO | Sell | 2,891 | $28.75 | $83,116.25 | -1.7% | |
| Jun 12, 2017 | Tamura Toshinari | Director | Sale+OE | 30,000 | $28.89 | $866,550.00 | -23.8% | |
| Jun 6, 2017 | Kearns Thomas F Jr | Director | Sale+OE | 18,000 | $28.71 | $516,780.00 | -11.5% | |
| May 31, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $26.21 | $1,012,530.94 | -0.4% | |
| May 16, 2017 | Kurkijarvi Kalevi | Director | Sell | 2,000 | $27.40 | $54,800.00 | -5.3% | |
| May 16, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $27.70 | $1,070,061.64 | -0.6% | |
| May 10, 2017 | Yu K Peony | Chief Medical Officer | Sell | 5,000 | $26.38 | $131,890.00 | -1.1% | |
| Apr 25, 2017 | Yu K Peony | Chief Medical Officer | Sale+OE | 5,000 | $28.00 | $140,000.00 | -2.1% | |
| Apr 25, 2017 | Cotroneo Pat | VP, Finance And CFO | Sale+OE | 6,500 | $28.00 | $182,000.00 | -4.0% | |
| Apr 25, 2017 | Neff Thomas B | Chief Executive Officer | Sale+OE | 38,636 | $26.92 | $1,040,198.16 | -0.6% |